Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Piper Methysticum Extract,Inapplicable
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Performance First
Deal Size : Inapplicable
Deal Type : Inapplicable
Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 19, 2022
Lead Product(s) : Piper Methysticum Extract,Inapplicable
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Performance First
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The extended collaboration will see the internalization of Thorne's disease discovery platform into AZ for further evaluation and to gain insight into additional uses for AZ molecules.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 08, 2022
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Quercetin Phytosome,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Indena
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Quercetin on Metabolic Health
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 25, 2022
Lead Product(s) : Quercetin Phytosome,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Indena
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Phosphatidylcholine-Curcumin Complex Supplement,Inapplicable
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Recipient : Columbia University
Deal Size : Inapplicable
Deal Type : Inapplicable
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 30, 2019
Lead Product(s) : Phosphatidylcholine-Curcumin Complex Supplement,Inapplicable
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Recipient : Columbia University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cardiopressin,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Nutraceutical Supplement in the Management of Hypertension
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 26, 2016
Lead Product(s) : Cardiopressin,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable